Case report: use of insulin-like growth factor-I gene expression to distinguish between breast and ovarian cancer.
Autocrine expression of polypeptide growth factors may be important in the growth regulation of cancer cells. Different growth factor activities have been identified in a variety of tumors. This article describes a case of malignant ascites in a patient recently treated for breast cancer. The use of growth factor mRNA expression as a factor to differentiate between breast and ovarian origins of cancer cells contained in malignant ascites was examined. Expression of insulin-like growth factor-I (IGF-I), IGF-II, and transforming growth factor alpha mRNA was examined by ribonuclease protection assay. The tumor cells expressed IGF-II and transforming growth factor alpha, but not IGF-I mRNA. This pattern of growth factor expression is compatible with a breast cancer primary of the malignant cells contained in the ascites fluid. Therefore, IGF-I mRNA expression may be useful in distinguishing between adenocarcinomas of breast or ovarian origins.
Yee
D
D
Department of Medicine/Oncology, University of Texas Health Science Center at San Antonio 78284-7884.
Jackson
J G
JG
Von Hoff
D D
DD
Ravdin
P M
PM
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000556:secondary* / Q000601:surgery; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D001201:Ascites / Q000378:metabolism / Q000473:pathology; D001943:Breast Neoplasms / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005260:Female; D015870:Gene Expression; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000096:biosynthesis*; D008099:Liver / Q000378:metabolism; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000601:surgery; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis*
D015295:Antigens, Tumor-Associated, Carbohydrate; D012333:RNA, Messenger; D007334:Insulin-Like Growth Factor I